H.A.M. van Diemen

512 total citations
10 papers, 404 citations indexed

About

H.A.M. van Diemen is a scholar working on Pathology and Forensic Medicine, Neurology and Ophthalmology. According to data from OpenAlex, H.A.M. van Diemen has authored 10 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 3 papers in Neurology and 3 papers in Ophthalmology. Recurrent topics in H.A.M. van Diemen's work include Multiple Sclerosis Research Studies (7 papers), Glaucoma and retinal disorders (3 papers) and Fungal Plant Pathogen Control (2 papers). H.A.M. van Diemen is often cited by papers focused on Multiple Sclerosis Research Studies (7 papers), Glaucoma and retinal disorders (3 papers) and Fungal Plant Pathogen Control (2 papers). H.A.M. van Diemen collaborates with scholars based in Netherlands and United Kingdom. H.A.M. van Diemen's co-authors include Chris H. Polman, J.C. Koetsier, A. C. Van Loenen, F.W. Bertelsmann, J. J. P. Nauta, Arie C. van Loenen, Jos J. P. Nauta, Martin Klein, P. Lanting and R.L.M. Strijers and has published in prestigious journals such as Annals of Neurology, Electroencephalography and Clinical Neurophysiology and Journal of the Neurological Sciences.

In The Last Decade

H.A.M. van Diemen

10 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H.A.M. van Diemen Netherlands 10 245 142 73 68 62 10 404
Mónica Perassolo Argentina 11 128 0.5× 136 1.0× 41 0.6× 69 1.0× 41 0.7× 23 275
M Delsedime Italy 11 133 0.5× 179 1.3× 66 0.9× 132 1.9× 66 1.1× 23 491
Shahrukh Mallik United Kingdom 4 183 0.7× 64 0.5× 43 0.6× 22 0.3× 18 0.3× 6 290
Anthony P. Turel United States 8 215 0.9× 115 0.8× 124 1.7× 101 1.5× 35 0.6× 10 444
M. J. Noronha United Kingdom 8 95 0.4× 49 0.3× 73 1.0× 29 0.4× 77 1.2× 17 296
Dean H. Kilfoyle New Zealand 7 70 0.3× 54 0.4× 100 1.4× 110 1.6× 8 0.1× 10 379
Jun Ichi Kira Japan 9 51 0.2× 75 0.5× 111 1.5× 49 0.7× 15 0.2× 59 322
Judit Füvesi Hungary 14 350 1.4× 66 0.5× 65 0.9× 11 0.2× 50 0.8× 31 472
Carolina Gabri Nicoletti Italy 14 354 1.4× 158 1.1× 90 1.2× 121 1.8× 31 0.5× 32 638
Angela Pisani Italy 6 399 1.6× 139 1.0× 147 2.0× 20 0.3× 65 1.0× 13 623

Countries citing papers authored by H.A.M. van Diemen

Since Specialization
Citations

This map shows the geographic impact of H.A.M. van Diemen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.A.M. van Diemen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.A.M. van Diemen more than expected).

Fields of papers citing papers by H.A.M. van Diemen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.A.M. van Diemen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.A.M. van Diemen. The network helps show where H.A.M. van Diemen may publish in the future.

Co-authorship network of co-authors of H.A.M. van Diemen

This figure shows the co-authorship network connecting the top 25 collaborators of H.A.M. van Diemen. A scholar is included among the top collaborators of H.A.M. van Diemen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.A.M. van Diemen. H.A.M. van Diemen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Polman, Chris H., F.W. Bertelsmann, Reneé de Waal, et al.. (1994). 4-Aminopyridine Is Superior to 3,4-Diaminopyridine in the Treatment of Patients With Multiple Sclerosis. Archives of Neurology. 51(11). 1136–1139. 47 indexed citations
2.
Nuyts, Rudy M. M. A., H.A.M. van Diemen, & Erik L. Greve. (1994). Occlusion of the retinal vasculature after trabeculectomy with mitomycin C. International Ophthalmology. 18(3). 167–170. 14 indexed citations
3.
Diemen, H.A.M. van, Chris H. Polman, J.C. Koetsier, et al.. (1993). 4-Aminopyridine in Patients with Multiple Sclerosis. Clinical Neuropharmacology. 16(3). 195–204. 69 indexed citations
4.
Diemen, H.A.M. van, Chris H. Polman, J. J. P. Nauta, et al.. (1993). 4-Aminopyridine induces functional improvement in multiple sclerosis patients: A neurophysiological study. Journal of the Neurological Sciences. 116(2). 220–226. 45 indexed citations
5.
Diemen, H.A.M. van, et al.. (1992). Evaluation of the visual system in multiple sclerosis: a comparative study of diagnostic tests. Clinical Neurology and Neurosurgery. 94(3). 191–195. 26 indexed citations
6.
Horst, Astrid van der, et al.. (1992). Determination of 4-aminopyridine in serum by solid-phase extraction and high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 574(1). 166–169. 10 indexed citations
7.
Diemen, H.A.M. van, et al.. (1992). Pupillary light reflex latency in patients with multiple sclerosis. Electroencephalography and Clinical Neurophysiology. 82(3). 213–219. 27 indexed citations
8.
Diemen, H.A.M. van, et al.. (1992). The effect of 4‐aminopyridine on clinical signs in multiple sclerosis: A randomized, placebo‐controlled, double‐blind, cross‐over study. Annals of Neurology. 32(2). 123–130. 110 indexed citations
9.
Diemen, H.A.M. van, et al.. (1992). A Pilot Study on the Influence of a Corticotropin (4-9) Analogue on Vinca Alkaloid--Induced Neuropathy. Archives of Neurology. 49(10). 1027–1031. 30 indexed citations
10.
Diemen, H.A.M. van, et al.. (1992). Increased Visual Impairment after Exercise (Uhthoff’s Phenomenon) in Multiple Sclerosis: Therapeutic Possibilities. European Neurology. 32(4). 231–234. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mónica Perassolo Breakdown of academic impact, for papers by M Delsedime Breakdown of academic impact, for papers by Shahrukh Mallik Breakdown of academic impact, for papers by Anthony P. Turel Breakdown of academic impact, for papers by M. J. Noronha Breakdown of academic impact, for papers by Dean H. Kilfoyle Breakdown of academic impact, for papers by Jun Ichi Kira Breakdown of academic impact, for papers by Judit Füvesi Breakdown of academic impact, for papers by Carolina Gabri Nicoletti Breakdown of academic impact, for papers by Angela Pisani
Rankless by CCL
2026